Multivariable analyses for disease severity
Variable | Imputed analysis* (n=694) | Available case analysis (n=601) | ||||
n/N | OR (95% CI) | P value | n/N | OR (95% CI) | P value | |
Age (years) | 87/694 | 1.08 (1.05–1.10) | <0.001 | 73/601 | 1.08 (1.05–1.10) | <0.001 |
Female gender | 44/462 | 0.45 (0.25–0.80) | 0.007 | 37/395 | 0.43 (0.24–0.78) | 0.005 |
BMI | 87/694 | 1.07 (1.02–1.12) | 0.006 | 73/601 | 1.07 (1.02–1.12) | 0.007 |
Hypertension | 51/182 | 1.86 (1.01–3.42) | 0.047 | 42/162 | 1.83 (0.99–3.37) | 0.054 |
Corticosteroids | 51/216 | 1.97 (1.09–3.54) | 0.024 | 45/188 | 2.04 (1.13–3.67) | 0.018 |
Mycophenolate mofetil/mycophenolic acid | 3/16 | 6.60 (1.47–29.62) | 0.014 | 3/14 | 6.51 (1.45–29.23) | 0.015 |
Rituximab | 11/34 | 4.21 (1.61–10.98) | 0.003 | 10/32 | 4.60 (1.75–12.11) | 0.002 |
ORs were calculated using multivariable penalised logistic regression models (Firth method), using a forward selection method, with patients with mild or moderate infection as reference. Only variables selected by the model are presented. Full model included age, sex, interstitial lung disease, diabetes, BMI, hypertension, chronic renal failure, disease history, corticosteroids, mycophenolate mofetil/mycophenolic acid and rituximab.
n/N indicated the number of events/number of cases.
*ORs and p value were calculated after multiple imputations (m=10) to handle missing data.
BMI, body mass index.